Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
June 1, 2019 Off

Five Prime Therapeutics Presents Monotherapy Data From the Phase 1a/1b Trial of FPA150 in Patients With Advanced Solid Tumors at the 2019 ASCO Annual Meeting

By BusinessWire

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative…

June 1, 2019 Off

Moderna Announces Presentation of Interim Data from Phase 1 Study of mRNA Personalized Cancer Vaccine at 2019 ASCO Annual Meeting

By BusinessWire

Data show the potential of using neoantigens identified from an individual’s tumor to elicit an immune response to cancer mutations…

June 1, 2019 Off

BioGENEius Challenge Announces 2019 Mentor of the Year Awardee

By BusinessWire

WASHINGTON–(BUSINESS WIRE)–Today, the Biotechnology Institute announced the winner of the Mentor of the Year Award, who will be recognized next…

June 1, 2019 Off

Intensity Therapeutics Presents Positive Preliminary Phase 1/2 Results for Intratumoral Injection of INT230-6 at ASCO 2019

By BusinessWire

INT230-6 well tolerated at all doses given Durable clinical benefit seen in multiple patients Increases in circulating and intratumoral CD4…

June 1, 2019 Off

Expanded Rubraca® (Rucaparib) Data from Clovis Oncology’s ARIEL3 and TRITON2 Trials in Ovarian and Prostate Cancers to be Presented at 2019 ASCO Annual Meeting

By BusinessWire

In exploratory analysis of ARIEL3 data, Rubraca significantly improved clinically meaningful endpoints including chemotherapy free interval and PFS on next…

June 1, 2019 Off

Five-Year Survival Data for Merck’s KEYTRUDA® (pembrolizumab) in Advanced Non-Small Cell Lung Cancer (NSCLC) from First KEYNOTE Trial at 2019 ASCO Annual Meeting

By BusinessWire

Longest Follow-Up Data for KEYTRUDA in Lung Cancer to Date Showed Five-Year Overall Survival Rate of 23.2% with KEYTRUDA in…

June 1, 2019 Off

ALX Oncology Presents New Data from Fully Enrolled ALX148 Clinical Trial Combination Cohorts for the Treatment of Patients with Advanced Solid Tumors

By BusinessWire

New Clinical Data Presented at the 2019 American Society of Clinical Oncology (ASCO) in Chicago, IL DUBLIN & BURLINGAME, Calif.–(BUSINESS…

June 1, 2019 Off

Medidata Recognized as the Only Company to be Both a Leader and Star Performer in Everest Group’s 2019 Life Sciences Clinical Trials Products PEAK Matrix™

By BusinessWire

Evaluation based upon market impact, plus vision and capability Medidata positioned as top company for impact created in market, which…

June 1, 2019 Off

ERLEADA®▼(apalutamide) Significantly Improved Overall Survival and Radiographic Progression-Free Survival in Patients with Metastatic Hormone-Sensitive Prostate Cancer

By BusinessWire

Phase 3 results featured in oral presentation at ASCO 2019, selected for Best of ASCO 2019 Meetings, and simultaneously published…

May 31, 2019 Off

BioUtah Congratulates Merit Medical Founder and CEO as Giant in our City Award Winner

By BusinessWire

SALT LAKE CITY–(BUSINESS WIRE)–BioUtah and Utah’s life sciences industry is proud to congratulate one of its own—Fred Lampropoulos, founder and…

Posts pagination

Previous 1 … 3,145 3,146 3,147 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine